As drug prices drop, generics makers fight back with deals – Reuters


Reuters

As drug prices drop, generics makers fight back with deals
Reuters
NEW YORK (Reuters) – Generic drug makers are turning to M&A to shield themselves against a concerted effort by U.S. regulators to crack down on steep drug prices. Impax Laboratories Inc (IPXL.O), Perrigo Company Plc (PRGO.N) and Alvogen Inc have …

and more »

Read More…

Share This: